NCT03457493View on ClinicalTrials.gov

The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

205

Participants

Timeline

Start Date

March 22, 2018

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions

Parkinson Disease

Interventions

DRUG

DPA-714-PET/MRI

DRUG

5-year Follow-up DPA-714-PET/MRI

PET/MRI scan with DPA-714

DRUG

DPA-714 Metabolite Analysis

Participants will have an arterial line placed in their lower forearm immediately before DPA-714 PET/MRI. Serial blood samples will be pulled at specific time points during the dynamic PET/MRI.

Trial Locations (1)

35294

RECRUITING

UAB Advanced Imaging Facility, Birmingham

All Listed Sponsors

lead

University of Alabama at Birmingham

OTHER